. 2025 Jan 28;22:100881. doi: 10.1016/j.resplu.2025.100881

Table 4.

Clinical outcomes in patients without underlying ESRD.

	AKI	No AKI	P-value
CPC 3-5, n (%)	152/184 (82.6%)	21/39 (53.8%)	<0.001
In-hospital mortality, n (%)	124/184 (67.4%)	15/39 (38.5%)	<0.001
6-month mortality, n (%)	125/167 (74.9%)	15/32 (46.9%)	0.002
1-year mortality, n (%)	127/160 (79.4%)	16/31 (51.6%)	0.001
2-year mortality, n (%)	129/156 (82.7%)	16/29 (55.2%)	<0.001

	AKI without recovery	AKI recovery	P-value

CPC 3-5, n (%)	116/127 (91.3%)	36/57 (63.2%)	<0.001
In-hospital mortality, n (%)	111/127 (87.4%)	13/57 (22.8%)	<0.001
6-month mortality, n (%)	112/124 (90.3%)	13/43 (30.2%)	<0.001
1-year mortality, n (%)	113/122 (92.6%)	14/38 (36.8%)	<0.001
2-year mortality, n (%)	115/121 (95.0%)	14/35 (40.0%)	<0.001
	Impaired eGFR_admission	Preserved eGFR_admission	P-value

CPC 3-5, n (n (%)	133/169 (78.7%)	40/54 (74.1)	0.478
In-hospital mortality, n (%)	110/169 (65.1%)	29/54 (53.7%)	0.133
6-month mortality, n (%)	111/153 (72.5%)	29/46 (63.0%)	0.216
1-year mortality, n (%)	113/148 (76.4%)	30/43 (69.8%)	0.381
2-year mortality, n (%)	115/145 (79.3%)	30/40 (75.0%)	0.558

	Impaired eGFR_predischarge	Preserved eGFR_predischarge	P-value

CPC 3-5, n (%)	118/136 (86.8%)	55/87 (63.2%)	<0.001
In-hospital mortality, n (%)	111/136 (81.6%)	28/87 (32.2%)	<0.001
6-month mortality, n (%)	112/132 (84.8%)	28/67 (41.8%)	<0.001
1-year mortality, n (%)	113/129 (87.6%)	30/62 (48.4%)	<0.001
2-year mortality, n (%)	115/127 (90.6%)	30/58 (51.7%)	<0.001

AKI, acute kidney injury; CI, confidence interval; CPC, cerebral performance category; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.